Follow the ASCENTAGE PHARMA GROUP INTERNATIONAL stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.7bn. The latest transaction was filed on 22 May 2026 (Levée d'options). Among the most active insiders: Yang Dajun. Every trade is openly available.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 25,251 of 29,064 companies
25.1
score / 100
Value
3
Quality
48
FCF yld-71%
Earn yld-73%
EV/EBITDA·
ROE-237%
Gross mgn91%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ASCENTAGE PHARMA GROUP INTERNATIONAL es una empresa centrada en el desarrollo de soluciones farmacéuticas innovadoras. Opera en el mercado de valores XNAS.